Navigation Links
Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression

ion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com.

References

(1) Wade et al. Current Medical Research and Opinion. Vol. 23, No 7, 2007,1605-1614 DOI: 10.1185/030079907X210732

(2) Jonas J, Bose A, Alexopoulos G, et al. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Poster presented at of Neuropsychopharmacology Congress, October 11-15 2006, Orlando, Florida, USA

(3) Bielski RJ, Ventura D. Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry. 2004; 65:1190-1196

(4) Montgomery SA, Andersen HF. Escitalopram versus venlafaxine XR in the treatment of depression. Int Clin Psychopharmacol 2006; 21:297-309

(5) Montgomery SA, Huusom AK, Rothmer J. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. J Neuropsychology. 2004; 50:57-64

(6) Nierenberg A, Greist J, Mallickrodt C, et al. Onset of antidepressant action and acute efficacy and safety of duloxetine versus escitalopram and placebo in the treatment of major depressive disorder. Neuropsychopharmacol 2005; 30(Suppl 1): S142

(7) Bostwick JM, Pakratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000; 157:1925-1932

(8) Depression. World Health Organisation. Last accessed on 06.11.06 from http://www.who.int/mental_health/management/depression/definition/en/

(9) Depression. National Institute for Mental Health. Last accessed on 09.11.06 from http://www.nimh.nih.gov/publicat/depression.cf
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
2. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
3. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
4. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
5. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
6. ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
7. MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
8. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
9. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
10. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
11. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
Post Your Comments:
(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Company (NYSE: ADM ) is pleased to ... effects of soy isoflavones in the alleviation of menopausal ... by Menopause: The Journal of The North American ... soy isoflavone supplements, like NovaSoy brand soy isoflavones, are ...
... /PRNewswire-iReach/ -- Global BioClinical (GBC) the Seattle-based contract ... a new website at www.globalbioclinical.com . The ... offered, partner registration, new search capabilities, and links ... The service descriptions function as a benchmark ...
Cached Medicine Technology:Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes 2Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes 3Global BioClinical Launches New Website 2
(Date:5/23/2013)... Camden, New Jersey (PRWEB) May 23, 2013 ... million Americans suffering from irritable bowel syndrome (IBS), the ... damper on your holiday fun. , “While hot dogs ... picnic plate during the warm weather months, IBS sufferers ... foods,” says Deborah Sokol, MD, a gastroenterologist with Lourdes ...
(Date:5/23/2013)... City, UT (PRWEB) May 23, 2013 ... , a comprehensive radiology learning environment for all ... prebuilt lessons and assessments, transforms the learning experience ... radiology curriculum. , “Until RADPrimer 3.0, ... second to none,” comments Dr. B.J. Manaster, Professor ...
(Date:5/23/2013)... (May 23, 2013)Don,t doubt it when a woman harried ... remembering things. A new study published online in ... Society (NAMS), helps confirm with objective tests that what ... In the past, some studies showed that hot flashes ... studies showed that, even though there was a relationship ...
(Date:5/23/2013)... being dragged to its destruction inside a cell, ... signals that thwart the development of tumor-suppressing microRNAs ... early online publication at Nature . , ... tumors, the epidermal growth factor receptor (EGFR) gums ... led by scientists at The University of Texas ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Transvaginal ... Bard, Inc., continue to move forward in a federal ... of West Virginia, Bernstein Liebhard LLP reports. In ... a request by C.R. Bard to seal emails that ... secrets and other confidential, proprietary information about its suppliers. ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3
... of Knowledge Award in the Biomedicine category goes in ... New York, United States), investigator in the Department of ... granted, in the words of the jury, "for his ... the largest, most versatile and most therapeutically accessible receptor ...
... research , WEDNESDAY, Jan. 27 (HealthDay News) -- Same-sex couples ... couples are, a review of 20 years of social science ... out there that children need both a mother and a ... professor of sociology and of social and cultural analysis at ...
... ... ... 27, 2010 -- Epocrates, Inc. and RealCME announced today ... an advanced technology platform that addresses the needs of CME providers, supporters and health ...
... ... and 104E industrial computers.,Percon rejoins the AIDC and industrial computer industries with their release of ... data terminals or fixed mount computers are designed to operate in the harshest of environments. ... (PRWEB) January 27, ...
... Interest in whether ... New York, medical malpractice attorneys say. , ... New York, NY (PRWEB) January 27, 2010 -- Medical professionals of any kind ... standards of practice in the medical community. Unfortunately, a number of issues may compromise this ...
... ... with over 30 years combined experience in the hospitality industry. Their knowledge of writing ... Hakuna combines the mind of a manger with the speed and processing power of ... (PRWEB) January ...
Cached Medicine News:Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 2Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 3Health News:Are Two Mommies as Good as Mom and Dad? 2Health News:Are Two Mommies as Good as Mom and Dad? 3Health News:Are Two Mommies as Good as Mom and Dad? 4Health News:Epocrates and RealCME Unite to Deliver Enhanced e-Learning Offerings 2Health News:Epocrates and RealCME Unite to Deliver Enhanced e-Learning Offerings 3Health News:Percon Delivers Maximum Value in New Industrial Vehicle Computer Products 2Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 2Health News:Tired Doctors Need More Rest According to New York Medical Malpractice Attorney, David Perecman 3Health News:Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... Sugar-Chex Linearity is a whole blood ... reportable range of the most popular ... recommendations of using a control matrix ... Linearity is packaged in ready-to-use dropper ...
Medicine Products: